SCHEMBL1469228

SCHEMBL1469228

CCC(CC)(N=C=N)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL538919 0.98
Hydrochloric Acid SCHEMBL8009052 0.76
SCHEMBL4768341 0.66
SCHEMBL6130560 0.65
SCHEMBL4629715 0.65
Ammonia Solution, Strong SCHEMBL27818154 0.63
Hydrochloric Acid SCHEMBL27523505 0.63
SCHEMBL7021307 0.63
Ammonia Solution, Strong SCHEMBL27583831 0.63 TSHR (0.30)
Hydrochloric Acid SCHEMBL7273267 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114401981-B Glucagon production method 北京费森尤斯卡比医药有限公司 2024-11-08 CN claimed
US-11566058-B2 Process for the preparation of high purity glucagon Fresenius Kabl iPSUM S.R.L. (IT) 2023-01-31 US claimed
US-20220324936-A1 PROCESS FOR THE MANUFACTURE OF GLUCAGON Fresenius Kabi Ipsum S.R.L. (IT) 2022-10-13 US claimed
EP-3986919-A1 PROCESS FOR THE MANUFACTURE OF GLUCAGON Fresenius Kabi iPSUM S.r.l. (IT) 2022-04-27 EP claimed
EP-3765488-A1 PROCESS FOR THE MANUFACTURE OF PTHRP ANALOGUE Fresenius Kabi iPSUM S.r.l. (IT) 2021-01-20 EP claimed
WO-2020254479-A1 PROCESS FOR THE MANUFACTURE OF GLUCAGON Fresenius Kabi Ipsum S.R.L. (IT) 2020-12-24 WO claimed
US-20200399339-A1 PROCESS FOR THE PREPARATION OF HIGH PURITY GLUCAGON Fresenius Kabi Ipsum S.R.L. (IT) 2020-12-24 US claimed
EP-3753946-A1 IMPROVED PROCESS FOR THE PREPARATION OF HIGH PURITY GLUCAGON Fresenius Kabi iPSUM S.r.l. (IT) 2020-12-23 EP claimed
WO-2019175173-A1 PROCESS FOR THE MANUFACTURE OF PTHRP ANALOGUE Fresenius Kabi Ipsum S.R.L. (IT) 2019-09-19 WO claimed
CN-100532382-C Novel process for the preparation of tiotropium salts BOEHRINGER INGELHEIM PHARMA (DE) 2009-08-26 CN claimed
CN-1481383-A Method for preparing anticholinergic agent tiotropium bromide ���ָ��Ӣ��ķ�������Ϲ�˾ 2004-03-10 CN claimed
US-20030170243-A1 Use of human plasma hyaluronidase in cancer treatment NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-09-11 US claimed
US-20030096734-A1 Sodium hyaluronate microspheres CLEAR SOLUTIONS BIOTECH, INC. 2003-05-22 US claimed
EP-0961833-A4 HUMAN PLASMA HYALURONIDASE UNIV CALIFORNIA (US) 2002-10-16 EP claimed
WO-2002041877-A1 SODIUM HYALURONATE MICROSPHERES CLEAR SOLUTIONS BIOTECH, INC. (US) 2002-05-30 WO claimed
EP-0961833-A1 HUMAN PLASMA HYALURONIDASE The Regents of the University of California (US) 1999-12-08 EP claimed
US-5783685-A Chemical preparation of high specific activity nucleotide probes ORTHO DIAGNOSTIC SYSTEMS, INC. (US) 1998-07-21 US claimed
WO-1998016655-A1 HUMAN PLASMA HYALURONIDASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-04-23 WO claimed
EP-0373956-B1 Nucleotide probes ORTHO DIAGNOSTIC SYSTEMS INC (US) 1995-07-26 EP claimed
US-5324829-A High specific activity nucleic acid probes having target recognition and signal generating moieties ORTHO DIAGNOSTIC SYSTEMS, INC. (US) 1994-06-28 US claimed